- Kiran Mazumdar-Shaw named niece Claire Mazumdar as Biocon's successor
- Claire Mazumdar is a biotech expert and founding CEO of Bicara Therapeutics
- Bicara Therapeutics went public in 2024 with a valuation over $1.6 billion
Biocon founder and chairperson Kiran Mazumdar-Shaw has formally outlined a succession plan for her biotechnology company, naming her niece Claire Mazumdar as her chosen successor. Mazumdar-Shaw, 73, who built Biocon into a leading biopharmaceutical enterprise over nearly four decades, said she is focused on ensuring the company remains in capable hands. As the sole owner with no children, she views Claire as a natural successor, citing her proven leadership and ability to run a global biotech business.
"I am the sole owner of Biocon, and I need to make sure that I put it in good hands... I have seen my niece Claire as my successor, because I think she has proved to me that she can run a company," she told Fortune India.
However, the transition is expected to be gradual. Mazumdar-Shaw has clarified that she is not stepping down immediately, noting that she will continue in her role while Claire progressively takes on greater responsibilities.
Who is Claire Mazumdar?
- Claire Mazumdar, 37, is a biotech specialist and the founding CEO of Bicara Therapeutics, a clinical-stage oncology firm incubated by Biocon.
- She led the company from inception to its NASDAQ listing in 2024, with its valuation crossing $800 million at debut and growing to over $1.6 billion in market capitalisation.
- Bicara's lead programme focuses on a bifunctional antibody targeting head and neck cancers and remains under clinical development with ongoing global trials -- an achievement Mazumdar-Shaw highlighted as evidence of Claire's capability to scale and lead in a competitive global environment.
- Academically, Claire has a strong scientific and business foundation. She holds a Bachelor's degree in Biological Engineering from Massachusetts Institute of Technology, a PhD in Cancer Biology from Stanford University School of Medicine, and an MBA from Stanford Graduate School of Business.
- Before founding Bicara, she worked at Third Rock Ventures, focusing on company creation, and at Rheos Medicines, where she contributed to a major global partnership with Roche.
- She also serves on the boards of Relay Therapeutics and Noora Health, which works to improve patient outcomes by training family caregivers.
- Claire is married to Thomas Roberts, an oncologist at Massachusetts General Hospital in the United States.
